Chief Executive Officer
Stuart joined the OBN Board in May 2022 with over 35 years’ experience in the life science arena. After graduating in biological sciences he started his career in pharmaceutical sales before moving into international marketing in consumer healthcare and prescription medicines.
His career spans global pharma companies, a university spin-out, mid cap biopharma, privately-owned SMEs, strategic consulting, advising PE & VC investors and leadership of a not-for-profit organisation. Prior to joining OBN he was Managing Director for Merz Pharma UK, building the business up to be one of the top 3 performing affiliates worldwide.
Stuart has also supported life sciences through roles including a Steering Group member for the Ethical Medicines Industry Group, the ABPI Small Companies Forum and a decade serving on the Prescription Medicines Code of Practice Authority Appeal Board. He is passionate about mentoring new talent and enjoys DIY, high-handicap golf and wine.